The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia

Pediatr Blood Cancer. 2015 Oct;62(10):1851-4. doi: 10.1002/pbc.25553. Epub 2015 Apr 29.

Abstract

Previous studies indicate pathophysiological and epidemiological parallels between osteonecrosis (ON) and thromboembolism (TE), two common treatment-related morbidities in acute lymphoblastic leukemia (ALL). To elucidate risk factors for ON and explore the relationship between ON and TE, we undertook a retrospective study of children (n = 208) with ALL. Twenty-one (10.1%) children developed ON and 42 (20.2%) TE on therapy. Thromboembolism was a significant predictor of ON on univariate (OR 8.85) and multivariate analysis, along with older age and PEGylated asparaginase. This observation supports a role for hypercoagulability in the pathogenesis of ON. Larger prospective studies are needed to further test these findings.

Keywords: acute lymphoblastic leukemia; oncology; osteonecrosis; pediatrics; thrombosis.

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Osteonecrosis / epidemiology
  • Osteonecrosis / etiology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Retrospective Studies
  • Risk Factors
  • Thromboembolism / epidemiology
  • Thromboembolism / etiology*